There are 15,355 results relating to "Medicin Viagra-m"
Order by
|
Questions and Answers
Date answered:
22 April 2002
S1W-24579
The medical conditions covered by the projects include: motor symptoms (including significant motor weakness affecting at least one leg), neurological symptoms and patients without conventionally defined organic disease who are frequently referred from primary care to a range of medical specialities including general surgery, orthopaedics, ear, nose and throat, urology, general medicine, cardiology, neurology and neurosurgery, gastroenterology, rheumatology, respiratory, gynaecology and infectious diseases.
Questions and Answers
Date answered:
26 March 2002
S1W-23163
To ask the Scottish Executive how the Health Technology Board for Scotland will eradicate any inequality of access to medicines through the issuing of guidance alone and whether it has any plans to make such guidance statutory in line with the rulings by the National Institute for Clinical Excellence.
Questions and Answers
Date answered:
6 November 2001
S1W-18463
I have asked the Health Technology Board for Scotland to provide NHSScotland with a Scottish Comment on the National Institute for Clinical Excellence (NICE) guidance on beta interferon and glatiramer when this is available. As with all medicines, the decision whether or not to prescribe beta interferon for an individual patient depends on the clinical judg...
Questions and Answers
Date answered:
19 September 2001
S1W-17683
This includes study towards the Diploma in Forensic Medicine and the Diploma in Medical Jurisprudence, undertaking Forensic Medical Examiners Course, attending the Edinburgh Coloscopy Course and the Newcastle Child Abuse Facility, induction training with paediatric staff, development and advanced training on sexual assaults and child abuse and attendance at...
Questions and Answers
Date answered:
4 September 2001
S1W-17428
We chose members to cover public health and clinical medicine, policing, and legal and judicial affairs.
Questions and Answers
Date answered:
19 March 2001
S1W-13175
To ask the Scottish Executive, further to the answer to question S1W-8790 by Susan Deacon on 20 November 2000, what response it has had from the Child Health Sub-Group of the National Screening Committee regarding the letter from W J McKenna, Professor of Cardiac Medicine at St George's Hospital Medical School, London regarding the likely incidence of hyp...
Questions and Answers
Date answered:
5 March 2001
S1W-12012
This policy is based on independent expert advice from the Joint Committee on Vaccination and Immunisation and the Committee on Safety of Medicines.MMR is considered the safest and most effective way to immunise against three serious and potentially fatal infections and, for this and other reasons, the Medicines Control Agency has restricted the import of t...
Questions and Answers
Date answered:
20 November 2000
S1W-08790
To ask the Scottish Executive whether it will review its assessment of the likely estimated level of cardiomyopathy in the light of the letter to the Minister for Health and Community Care of 26 May 2000 from W J McKenna, Professor of Cardiac Medicine at St George's Hospital Medical School in London given the difference in estimated level between this lett...
Questions and Answers
Date answered:
14 November 2000
S1W-10785
To ask the Scottish Executive what is being done to address the current waiting times for treatment at the Glasgow Dental Hospital of (i) 71 weeks for oral medicine, (ii) 69 weeks for anxiety/hypnosis, (iii) 11 months for prosthodontics, (iv) 34 weeks for oral surgery, (v) 30 weeks for conservation, (vi) 22 weeks for child's dental health and (vii) 19 week...
Questions and Answers
Date answered:
9 December 1999
S1W-02774
To ask the Scottish Executive whether it will investigate the distribution of Beta Interferon and end "post code medicine". The Scottish Health Technology Assessment Centre (SHTAC), which will begin operation in spring 2000, will act as a single focus for advice on the clinical and cost-effectiveness of new health technologies, including drugs.
